Search results
A champion of psychedelics who includes a dose of skepticism
LA Times via AOL· 1 day agoThey relieve him of depression and suicidality. He then continues to “trip” to engage in...
Ketamine bros are giving psychedelics a bad rap. That's a problem for those who need them.
USA TODAY Opinion via Yahoo News· 2 weeks agoShe couldn’t string two sentences together. When...now, I can’t even think straight.” Such is the...
Everything You Should Know About Psychedelic Travel Experiences
Travel Noire via Yahoo News· 6 days agoIt’s a trip that forces you to look within, break down barriers, and discover the interconnectedness...
The longest, strangest trip: Some psychedelic drug users are stuck with unwelcome highs
Los Angeles Times· 5 days agoA.J. took two small hits off a cannabis vape pen, a common ritual with his morning coffee. A.J. —...
Business Tripping: The Professionals Trying Drugs to Get Better at Work
The Wall Street Journal· 2 weeks agoWhitcomb says he initially turned to ketamine to treat depression and found it helped him think more...
Psilocybin Shows Promise for Treatment-Resistant Depression – But Is It Safe?
Technology Networks· 2 weeks agoCommonly referred to as “magic mushrooms,” psilocybin is a promising alternative treatment for...
Tech bros love talking about microdosing – but the legality of psychedelics is a messy grey area
The Independent US via AOL· 1 week agoDespite surging social and scientific support for drugs such as psilocybin, many advocates still...
MPM BioImpact-owned Reunion raises $103M, one of the largest rounds for a psychedelic biotech
FierceBiotech· 3 days agoReunion Neuroscience has cashed in on a $103 million series A, building on the promise of a phase 2-stage psychedelic prodrug being developed as a treatment for postpartum ...
Fish under the influence reveal how psychedelics work
Medical Xpress· 2 weeks agoTakashi Kawashima at the Weizmann Institute of Science has developed a new approach that makes it possible to observe how psychedelics influence behavior and</ ...
Reunion raises over $100M to build a better psychedelic drug
BioPharma Dive via Yahoo Finance· 3 days agoThe funding will help Reunion pay for a mid-stage study testing its most advanced medicine —...